AI-Enhanced Lung Cancer Prediction: A Hybrid Model's Precision Triumph

Lung cancer is considered one of the most dangerous cancers, with a 5-year survival rate, ranking the disease among the top three deadliest cancers globally. Effectively combating lung cancer requires early detection for timely targeted interventions. However, ensuring early detection poses a major challenge, giving rise to innovative approaches. The emergence of artificial intelligence offers revolutionary solutions for predicting cancer. While marking a significant healthcare shift, the imperative to enhance artificial intelligence models remains a focus, particularly in precision medicine. This study introduces a hybrid deep learning model, incorporating Convolutional Neural Networks (CNN) and Bidirectional Long Short-Term Memory Networks (BiLSTM), designed for lung cancer detection from patients' medical notes. Comparative analysis with the MIMIC IV dataset reveals the model's superiority, achieving an MCC of 96.2% with an Accuracy of 98.1%, and outperforming LSTM and BioBERT with an MCC of 93.5%, an accuracy of 97.0% and MCC of 95.5 with an accuracy of 98.0% respectively. Another comprehensive comparison was conducted with state-of-the-art results using the Yelp Review Polarity dataset. Remarkably, our model significantly outperforms the compared models, showcasing its superior performance and potential impact in the field. This research signifies a significant stride toward precise and early lung cancer detection, emphasizing the ongoing necessity for Artificial Intelligence model refinement in precision medicine.